Bioventix PLC (LON:BVXP – Get Free Report) announced a dividend on Monday, October 28th, Upcoming.Co.Uk reports. Investors of record on Thursday, November 7th will be given a dividend of GBX 87 ($1.13) per share by the biotechnology company on Thursday, November 21st. This represents a dividend yield of 2.4%. The ex-dividend date is Thursday, November 7th. This is a boost from Bioventix’s previous dividend of $68.00. The official announcement can be seen at this link.
Bioventix Stock Up 0.3 %
Shares of LON BVXP opened at GBX 3,660 ($47.64) on Wednesday. The firm has a market capitalization of £191.05 million, a P/E ratio of 2,264.42 and a beta of 0.35. The stock’s 50-day simple moving average is GBX 3,838.65 and its two-hundred day simple moving average is GBX 4,154.79. Bioventix has a twelve month low of GBX 2,977 ($38.75) and a twelve month high of GBX 5,100 ($66.39).
Insider Activity
In related news, insider Bruce Hiscock bought 300 shares of the company’s stock in a transaction that occurred on Wednesday, October 30th. The stock was bought at an average cost of GBX 3,330 ($43.35) per share, for a total transaction of £9,990 ($13,004.43). Corporate insiders own 8.02% of the company’s stock.
Bioventix Company Profile
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants.
Further Reading
- Five stocks we like better than Bioventix
- How to Read Stock Charts for Beginners
- 2 Alternative Internet Stocks Staging a Breakout in 2024
- Profitably Trade Stocks at 52-Week Highs
- Discover the 3 Best-Performing Biotech IPO Stocks of 2024
- Quiet Period Expirations Explained
- Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
Receive News & Ratings for Bioventix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bioventix and related companies with MarketBeat.com's FREE daily email newsletter.